Major Bayer investor 'deeply concerned' about move for Monsanto

A top investor in German chemicals company Bayer said he was "deeply concerned" about a potential acquisition of U.S. rival Monsanto, and would prefer the firms to agree a joint venture or a nil-premium merger. Maximillian Anderl, a fund manager at UBS Global Asset Management, said he was surprised by Bayer's unsolicited takeover approach given the management team was fairly new and settling in, and a recent acquisition in consumer health had yet to be integrated successfully. "We are deeply con